Login / Signup

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study.

Xenofon BaraliakosDésirée van der HeijdeJoachim SieperRobert D InmanHideto KamedaYihan LiXianwei BuAnna ShmagelPeter WungIn-Ho SongAtul Deodhar
Published in: Arthritis research & therapy (2023)
NCT02049138.
Keyphrases